# Venu Holding Corp: financial statements, quarterly

VENU · NYSE · CIK 1770501 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/venu.md) · [Financials](/companies/venu/financials.md) · [Filings](/companies/venu/filings.md) · [Insiders](/companies/venu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/venu/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.9](/filings/0001493152-24-051822.md) | [3.9 d](/filings/0001641172-25-001676.md) | [3.9](/filings/0001641172-25-010885.md) | [4.2](/filings/0001641172-25-024018.md) | [5.5](/filings/0001493152-25-023463.md) | [4.3 d](/filings/0001493152-26-014137.md) | [3.5](/filings/0001493152-26-023363.md) | [4.5](/filings/0001493152-26-037568.md) | [5.4](/filings/0001493152-25-023463.md) | [4.5 d](/filings/0001493152-26-014137.md) | [3.9](/filings/0001493152-26-023363.md) | [4.8](/filings/0001493152-26-037568.md) |
| Operating income | $m | [(2.8)](/filings/0001493152-24-051822.md) | [(3.0) d](/filings/0001641172-25-001676.md) | [(13.0)](/filings/0001641172-25-010885.md) | [(4.4)](/filings/0001641172-25-024018.md) | [(3.7)](/filings/0001493152-25-023463.md) | [(6.4) d](/filings/0001493152-26-014137.md) | [(18.5)](/filings/0001493152-26-023363.md) | [(10.3)](/filings/0001493152-26-037568.md) | [(10.0)](/filings/0001493152-25-023463.md) | [(7.3) d](/filings/0001493152-26-014137.md) | [(11.5)](/filings/0001493152-26-023363.md) | [(15.3)](/filings/0001493152-26-037568.md) |
| Interest expense | $m | [0.1](/filings/0001493152-24-051822.md) | [0.1 d](/filings/0001641172-25-001676.md) | [0.4](/filings/0001641172-25-010885.md) | [1.2](/filings/0001641172-25-024018.md) | [0.0](/filings/0001493152-25-023463.md) | [3.2 d](/filings/0001493152-26-014137.md) | [1.1](/filings/0001641172-25-010885.md) | [2.0](/filings/0001641172-25-024018.md) | [0.3](/filings/0001493152-25-023463.md) | [4.2 d](/filings/0001493152-26-014137.md) | not reported | not reported |
| Net income | $m | [(2.8)](/filings/0001493152-24-051822.md) | [(2.8) d](/filings/0001641172-25-001676.md) | [(15.6)](/filings/0001641172-25-010885.md) | [(5.3)](/filings/0001493152-25-023463.md) | [(3.9)](/filings/0001493152-25-023463.md) | [(6.3) d](/filings/0001493152-26-014137.md) | [(18.1)](/filings/0001493152-26-023363.md) | [(11.4)](/filings/0001493152-26-037568.md) | [(6.4)](/filings/0001493152-25-023463.md) | [(8.3) d](/filings/0001493152-26-014137.md) | [(13.8)](/filings/0001493152-26-023363.md) | [(17.9)](/filings/0001493152-26-037568.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.13)](/filings/0001493152-25-023463.md) | not reported | [(0.48)](/filings/0001493152-26-023363.md) | [(0.30)](/filings/0001493152-26-037568.md) | [(0.15)](/filings/0001493152-25-023463.md) | not reported | [(0.29)](/filings/0001493152-26-023363.md) | [(0.30)](/filings/0001493152-26-037568.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [(0.13)](/filings/0001493152-25-023463.md) | not reported | [(0.48)](/filings/0001493152-26-023363.md) | [(0.30)](/filings/0001493152-26-037568.md) | [(0.15)](/filings/0001493152-25-023463.md) | not reported | [(0.29)](/filings/0001493152-26-023363.md) | [(0.30)](/filings/0001493152-26-037568.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [20.2](/filings/0001641172-25-001676.md) | not reported | not reported | [35.8](/filings/0001493152-24-051822.md) | [38.0](/filings/0001493152-26-014137.md) | [24.7](/filings/0001641172-25-010885.md) | [37.4](/filings/0001641172-25-024018.md) | [58.2](/filings/0001493152-25-023463.md) | [41.3](/filings/0001493152-26-037568.md) | [56.6](/filings/0001493152-26-023363.md) | [16.3](/filings/0001493152-26-037568.md) |
| Current assets | $m | not reported | [20.6](/filings/0001641172-25-001676.md) | not reported | not reported | [38.6](/filings/0001493152-24-051822.md) | [39.0](/filings/0001493152-26-014137.md) | [25.8](/filings/0001641172-25-010885.md) | [38.9](/filings/0001641172-25-024018.md) | [60.7](/filings/0001493152-25-023463.md) | [44.3](/filings/0001493152-26-037568.md) | [59.7](/filings/0001493152-26-023363.md) | [20.4](/filings/0001493152-26-037568.md) |
| Total assets | $m | not reported | [83.2](/filings/0001641172-25-001676.md) | not reported | not reported | [167](/filings/0001493152-24-051822.md) | [178](/filings/0001493152-26-014137.md) | [213](/filings/0001641172-25-010885.md) | [242](/filings/0001641172-25-024018.md) | [315](/filings/0001493152-25-023463.md) | [371](/filings/0001493152-26-037568.md) | [461](/filings/0001493152-26-023363.md) | [512](/filings/0001493152-26-037568.md) |
| Current liabilities | $m | not reported | [4.9](/filings/0001641172-25-001676.md) | not reported | not reported | [30.6](/filings/0001493152-24-051822.md) | [24.5](/filings/0001493152-26-014137.md) | [9.5](/filings/0001641172-25-010885.md) | [14.3](/filings/0001641172-25-024018.md) | [30.1](/filings/0001493152-25-023463.md) | [57.4](/filings/0001493152-26-037568.md) | [66.1](/filings/0001493152-26-023363.md) | [82.9](/filings/0001493152-26-037568.md) |
| Total liabilities | $m | not reported | [21.2](/filings/0001641172-25-001676.md) | not reported | not reported | [52.6](/filings/0001493152-24-051822.md) | [47.6](/filings/0001493152-26-014137.md) | [73.6](/filings/0001641172-25-010885.md) | [68.1](/filings/0001641172-25-024018.md) | [108](/filings/0001493152-25-023463.md) | [172](/filings/0001493152-26-037568.md) | [186](/filings/0001493152-26-023363.md) | [263](/filings/0001493152-26-037568.md) |
| Long-term debt | $m | not reported | [11.2](/filings/0001641172-25-001676.md) | not reported | not reported | [14.0](/filings/0001493152-24-051822.md) | [14.1](/filings/0001493152-26-014137.md) | [54.7](/filings/0001641172-25-010885.md) | [44.8](/filings/0001641172-25-024018.md) | [58.9](/filings/0001493152-25-023463.md) | [56.6](/filings/0001493152-26-037568.md) | [56.5](/filings/0001493152-26-023363.md) | [56.1](/filings/0001493152-26-037568.md) |
| Current portion of debt | $m | not reported | [0.3](/filings/0001641172-25-001676.md) | not reported | not reported | [8.8](/filings/0001493152-24-051822.md) | [11.5](/filings/0001493152-25-023463.md) | [0.3](/filings/0001641172-25-010885.md) | [0.3](/filings/0001641172-25-024018.md) | [0.4](/filings/0001493152-25-023463.md) | [0.4](/filings/0001493152-26-037568.md) | [8.2](/filings/0001493152-26-023363.md) | [8.2](/filings/0001493152-26-037568.md) |
| Shareholders' equity | $m | [57.5](/filings/0001493152-24-051822.md) | [30.8](/filings/0001641172-25-001676.md) | [91.6](/filings/0001493152-25-023463.md) | [108](/filings/0001493152-25-023463.md) | [79.4](/filings/0001493152-24-051822.md) | [95.7](/filings/0001493152-26-014137.md) | [78.4](/filings/0001641172-25-010885.md) | [90.2](/filings/0001641172-25-024018.md) | [121](/filings/0001493152-25-023463.md) | [102](/filings/0001493152-26-037568.md) | [160](/filings/0001493152-26-023363.md) | [136](/filings/0001493152-26-037568.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.6 d](/filings/0001641172-25-001676.md) | [(2.7)](/filings/0001641172-25-010885.md) | [8.8 d](/filings/0001641172-25-024018.md) | [7.2 d](/filings/0001493152-25-023463.md) | [(9.6) d](/filings/0001493152-26-014137.md) | [(9.0)](/filings/0001493152-26-023363.md) | [(2.4) d](/filings/0001493152-26-037568.md) | [6.3 d](/filings/0001493152-25-023463.md) | [12.8 d](/filings/0001493152-26-014137.md) | [(8.5)](/filings/0001493152-26-023363.md) | [(0.9) d](/filings/0001493152-26-037568.md) |
| Capital expenditure | $m | [12.0 d](/filings/0001641172-25-001676.md) | [8.9](/filings/0001641172-25-010885.md) | [22.3 d](/filings/0001641172-25-024018.md) | [30.4 d](/filings/0001493152-25-023463.md) | [10.9 d](/filings/0001493152-26-014137.md) | [22.0](/filings/0001493152-26-023363.md) | [15.2 d](/filings/0001493152-26-037568.md) | [39.2 d](/filings/0001493152-25-023463.md) | [65.2 d](/filings/0001493152-26-014137.md) | [65.9](/filings/0001493152-26-023363.md) | [67.0 d](/filings/0001493152-26-037568.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3.3](/filings/0001493152-25-023463.md) | [37.5](/filings/0001493152-26-023363.md) | [38.0](/filings/0001493152-26-037568.md) | [41.4](/filings/0001493152-25-023463.md) | [47.1](/filings/0001493152-26-023363.md) | [59.5](/filings/0001493152-26-037568.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 56,210,552 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037568.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.